European Parliament fails to eliminate devices from pharma regulation review
This article was originally published in Clinica
Executive Summary
The European Parliament did not go far enough for the medical devices industry in restricting the definition of a pharmaceutical when it voted on the review of EU the pharmaceuticals legislation on October 23. It failed to add the condition that would have ensured that products currently regulated as medical devices, but which are on the drug/device borderline, remain clearly under the control of the device regime.